WHO Halts Testing of Trump Wonder Drug Hydroxychloroquine Over Safety Concerns
Trump has fiercely advocated for the drug as an unproven coronavirus treatment and claimed that he’s been taking it despite warnings about its serious side effects.

Fabrice Coffrini/Getty
The World Health Organization said on Monday that it will temporarily suspend clinical trials of hydroxychloroquine, the anti-malarial drug President Trump has been touting as a coronavirus treatment, due to safety concerns. WHO director-general Tedros Adhanom Ghebreyesus cited a study published in The Lancet last week that found coronavirus patients taking hydroxychloroquine were more likely to die or suffer heart problems. Tedros said that there will be a “temporary pause” on testing the drug as the agency’s Data Safety Monitoring Board reviews “a comprehensive analysis and critical appraisal of all evidence available globally.” The director added that hydroxychloroquine and chloroquine are “accepted as generally safe for use in patients with autoimmune diseases or malaria.” Trump has fiercely advocated for the drug as a “game-changer” with “rave reviews” and claimed last week that he’s been taking it despite warnings from the FDA about its potentially deadly side effects.
Register below to read this article for free or subscribe
to unlock unlimited access to The Daily Beast.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Already have an account? Sign In
Looks like you already have a subscription!
You're all set!
Thanks for subscribing.